Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives Article Swipe
Ke-Yu Shen
,
Ying Zhu
,
Sun‐Zhe Xie
,
Lun–Xiu Qin
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1186/s13045-024-01549-2
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1186/s13045-024-01549-2
Related Topics
Concepts
Tremelimumab
Durvalumab
Medicine
Immunotherapy
Hepatocellular carcinoma
Oncolytic virus
Immune checkpoint
Immunology
Tumor microenvironment
Oncology
Ipilimumab
Nivolumab
Chimeric antigen receptor
Hematology
Immune system
Internal medicine
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1186/s13045-024-01549-2
- https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2
- OA Status
- gold
- Cited By
- 102
- References
- 230
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4396227371
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4396227371Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s13045-024-01549-2Digital Object Identifier
- Title
-
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectivesWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-04-29Full publication date if available
- Authors
-
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, Lun–Xiu QinList of authors in order
- Landing page
-
https://doi.org/10.1186/s13045-024-01549-2Publisher landing page
- PDF URL
-
https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2Direct OA link when available
- Concepts
-
Tremelimumab, Durvalumab, Medicine, Immunotherapy, Hepatocellular carcinoma, Oncolytic virus, Immune checkpoint, Immunology, Tumor microenvironment, Oncology, Ipilimumab, Nivolumab, Chimeric antigen receptor, Hematology, Immune system, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
102Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 85, 2024: 17Per-year citation counts (last 5 years)
- References (count)
-
230Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4396227371 |
|---|---|
| doi | https://doi.org/10.1186/s13045-024-01549-2 |
| ids.doi | https://doi.org/10.1186/s13045-024-01549-2 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38679698 |
| ids.openalex | https://openalex.org/W4396227371 |
| fwci | 58.0766479 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000628 |
| mesh[1].descriptor_ui | D006528 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | therapy |
| mesh[1].descriptor_name | Carcinoma, Hepatocellular |
| mesh[2].qualifier_ui | Q000276 |
| mesh[2].descriptor_ui | D006528 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | immunology |
| mesh[2].descriptor_name | Carcinoma, Hepatocellular |
| mesh[3].qualifier_ui | Q000628 |
| mesh[3].descriptor_ui | D008113 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | therapy |
| mesh[3].descriptor_name | Liver Neoplasms |
| mesh[4].qualifier_ui | Q000276 |
| mesh[4].descriptor_ui | D008113 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | immunology |
| mesh[4].descriptor_name | Liver Neoplasms |
| mesh[5].qualifier_ui | Q000276 |
| mesh[5].descriptor_ui | D059016 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | immunology |
| mesh[5].descriptor_name | Tumor Microenvironment |
| mesh[6].qualifier_ui | Q000379 |
| mesh[6].descriptor_ui | D007167 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | methods |
| mesh[6].descriptor_name | Immunotherapy |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D000082082 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D019496 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Cancer Vaccines |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000818 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Animals |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000628 |
| mesh[11].descriptor_ui | D006528 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | therapy |
| mesh[11].descriptor_name | Carcinoma, Hepatocellular |
| mesh[12].qualifier_ui | Q000276 |
| mesh[12].descriptor_ui | D006528 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | immunology |
| mesh[12].descriptor_name | Carcinoma, Hepatocellular |
| mesh[13].qualifier_ui | Q000628 |
| mesh[13].descriptor_ui | D008113 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | therapy |
| mesh[13].descriptor_name | Liver Neoplasms |
| mesh[14].qualifier_ui | Q000276 |
| mesh[14].descriptor_ui | D008113 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | immunology |
| mesh[14].descriptor_name | Liver Neoplasms |
| mesh[15].qualifier_ui | Q000276 |
| mesh[15].descriptor_ui | D059016 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | immunology |
| mesh[15].descriptor_name | Tumor Microenvironment |
| mesh[16].qualifier_ui | Q000379 |
| mesh[16].descriptor_ui | D007167 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | methods |
| mesh[16].descriptor_name | Immunotherapy |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D000082082 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D019496 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Cancer Vaccines |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000818 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Animals |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | Q000628 |
| mesh[21].descriptor_ui | D006528 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | therapy |
| mesh[21].descriptor_name | Carcinoma, Hepatocellular |
| mesh[22].qualifier_ui | Q000276 |
| mesh[22].descriptor_ui | D006528 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | immunology |
| mesh[22].descriptor_name | Carcinoma, Hepatocellular |
| mesh[23].qualifier_ui | Q000628 |
| mesh[23].descriptor_ui | D008113 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | therapy |
| mesh[23].descriptor_name | Liver Neoplasms |
| mesh[24].qualifier_ui | Q000276 |
| mesh[24].descriptor_ui | D008113 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | immunology |
| mesh[24].descriptor_name | Liver Neoplasms |
| mesh[25].qualifier_ui | Q000276 |
| mesh[25].descriptor_ui | D059016 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | immunology |
| mesh[25].descriptor_name | Tumor Microenvironment |
| mesh[26].qualifier_ui | Q000379 |
| mesh[26].descriptor_ui | D007167 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | methods |
| mesh[26].descriptor_name | Immunotherapy |
| mesh[27].qualifier_ui | Q000627 |
| mesh[27].descriptor_ui | D000082082 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | therapeutic use |
| mesh[27].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D019496 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Cancer Vaccines |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000818 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Animals |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006801 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Humans |
| mesh[31].qualifier_ui | Q000628 |
| mesh[31].descriptor_ui | D006528 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | therapy |
| mesh[31].descriptor_name | Carcinoma, Hepatocellular |
| mesh[32].qualifier_ui | Q000276 |
| mesh[32].descriptor_ui | D006528 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | immunology |
| mesh[32].descriptor_name | Carcinoma, Hepatocellular |
| mesh[33].qualifier_ui | Q000628 |
| mesh[33].descriptor_ui | D008113 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | therapy |
| mesh[33].descriptor_name | Liver Neoplasms |
| mesh[34].qualifier_ui | Q000276 |
| mesh[34].descriptor_ui | D008113 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | immunology |
| mesh[34].descriptor_name | Liver Neoplasms |
| mesh[35].qualifier_ui | Q000276 |
| mesh[35].descriptor_ui | D059016 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | immunology |
| mesh[35].descriptor_name | Tumor Microenvironment |
| mesh[36].qualifier_ui | Q000379 |
| mesh[36].descriptor_ui | D007167 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | methods |
| mesh[36].descriptor_name | Immunotherapy |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D000082082 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[38].qualifier_ui | Q000627 |
| mesh[38].descriptor_ui | D019496 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | therapeutic use |
| mesh[38].descriptor_name | Cancer Vaccines |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D000818 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Animals |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | Q000628 |
| mesh[41].descriptor_ui | D006528 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | therapy |
| mesh[41].descriptor_name | Carcinoma, Hepatocellular |
| mesh[42].qualifier_ui | Q000276 |
| mesh[42].descriptor_ui | D006528 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | immunology |
| mesh[42].descriptor_name | Carcinoma, Hepatocellular |
| mesh[43].qualifier_ui | Q000628 |
| mesh[43].descriptor_ui | D008113 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | therapy |
| mesh[43].descriptor_name | Liver Neoplasms |
| mesh[44].qualifier_ui | Q000276 |
| mesh[44].descriptor_ui | D008113 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | immunology |
| mesh[44].descriptor_name | Liver Neoplasms |
| mesh[45].qualifier_ui | Q000276 |
| mesh[45].descriptor_ui | D059016 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | immunology |
| mesh[45].descriptor_name | Tumor Microenvironment |
| mesh[46].qualifier_ui | Q000379 |
| mesh[46].descriptor_ui | D007167 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | methods |
| mesh[46].descriptor_name | Immunotherapy |
| mesh[47].qualifier_ui | Q000627 |
| mesh[47].descriptor_ui | D000082082 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | therapeutic use |
| mesh[47].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[48].qualifier_ui | Q000627 |
| mesh[48].descriptor_ui | D019496 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | therapeutic use |
| mesh[48].descriptor_name | Cancer Vaccines |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D000818 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Animals |
| type | review |
| title | Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives |
| awards[0].id | https://openalex.org/G6718250685 |
| awards[0].funder_id | https://openalex.org/F4320321001 |
| awards[0].display_name | |
| awards[0].funder_award_id | No.82273312, No.82072696, No.82203792 |
| awards[0].funder_display_name | National Natural Science Foundation of China |
| biblio.issue | 1 |
| biblio.volume | 17 |
| biblio.last_page | 25 |
| biblio.first_page | 25 |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T10580 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9994000196456909 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Immunotherapy and Immune Responses |
| topics[2].id | https://openalex.org/T10073 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9976999759674072 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2721 |
| topics[2].subfield.display_name | Hepatology |
| topics[2].display_name | Hepatocellular Carcinoma Treatment and Prognosis |
| funders[0].id | https://openalex.org/F4320321001 |
| funders[0].ror | https://ror.org/01h0zpd94 |
| funders[0].display_name | National Natural Science Foundation of China |
| is_xpac | False |
| apc_list.value | 2790 |
| apc_list.currency | GBP |
| apc_list.value_usd | 3422 |
| apc_paid.value | 2790 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 3422 |
| concepts[0].id | https://openalex.org/C2778650287 |
| concepts[0].level | 5 |
| concepts[0].score | 0.8659927845001221 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7838098 |
| concepts[0].display_name | Tremelimumab |
| concepts[1].id | https://openalex.org/C2777742743 |
| concepts[1].level | 5 |
| concepts[1].score | 0.8293439149856567 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q19904005 |
| concepts[1].display_name | Durvalumab |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.79599928855896 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2777701055 |
| concepts[3].level | 3 |
| concepts[3].score | 0.7410573959350586 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[3].display_name | Immunotherapy |
| concepts[4].id | https://openalex.org/C2778019345 |
| concepts[4].level | 2 |
| concepts[4].score | 0.58067786693573 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1148337 |
| concepts[4].display_name | Hepatocellular carcinoma |
| concepts[5].id | https://openalex.org/C82210918 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5539763569831848 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1560099 |
| concepts[5].display_name | Oncolytic virus |
| concepts[6].id | https://openalex.org/C2780851360 |
| concepts[6].level | 4 |
| concepts[6].score | 0.5258952975273132 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[6].display_name | Immune checkpoint |
| concepts[7].id | https://openalex.org/C203014093 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4951530992984772 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[7].display_name | Immunology |
| concepts[8].id | https://openalex.org/C2776107976 |
| concepts[8].level | 3 |
| concepts[8].score | 0.48770269751548767 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[8].display_name | Tumor microenvironment |
| concepts[9].id | https://openalex.org/C143998085 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4861607253551483 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[9].display_name | Oncology |
| concepts[10].id | https://openalex.org/C2781433595 |
| concepts[10].level | 4 |
| concepts[10].score | 0.48469972610473633 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2459042 |
| concepts[10].display_name | Ipilimumab |
| concepts[11].id | https://openalex.org/C2780030458 |
| concepts[11].level | 4 |
| concepts[11].score | 0.4557572901248932 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7041828 |
| concepts[11].display_name | Nivolumab |
| concepts[12].id | https://openalex.org/C3875195 |
| concepts[12].level | 4 |
| concepts[12].score | 0.4403367042541504 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q5099363 |
| concepts[12].display_name | Chimeric antigen receptor |
| concepts[13].id | https://openalex.org/C194409129 |
| concepts[13].level | 2 |
| concepts[13].score | 0.4362955093383789 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q103824 |
| concepts[13].display_name | Hematology |
| concepts[14].id | https://openalex.org/C8891405 |
| concepts[14].level | 2 |
| concepts[14].score | 0.43156078457832336 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[14].display_name | Immune system |
| concepts[15].id | https://openalex.org/C126322002 |
| concepts[15].level | 1 |
| concepts[15].score | 0.3803994655609131 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[15].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/tremelimumab |
| keywords[0].score | 0.8659927845001221 |
| keywords[0].display_name | Tremelimumab |
| keywords[1].id | https://openalex.org/keywords/durvalumab |
| keywords[1].score | 0.8293439149856567 |
| keywords[1].display_name | Durvalumab |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.79599928855896 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/immunotherapy |
| keywords[3].score | 0.7410573959350586 |
| keywords[3].display_name | Immunotherapy |
| keywords[4].id | https://openalex.org/keywords/hepatocellular-carcinoma |
| keywords[4].score | 0.58067786693573 |
| keywords[4].display_name | Hepatocellular carcinoma |
| keywords[5].id | https://openalex.org/keywords/oncolytic-virus |
| keywords[5].score | 0.5539763569831848 |
| keywords[5].display_name | Oncolytic virus |
| keywords[6].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[6].score | 0.5258952975273132 |
| keywords[6].display_name | Immune checkpoint |
| keywords[7].id | https://openalex.org/keywords/immunology |
| keywords[7].score | 0.4951530992984772 |
| keywords[7].display_name | Immunology |
| keywords[8].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[8].score | 0.48770269751548767 |
| keywords[8].display_name | Tumor microenvironment |
| keywords[9].id | https://openalex.org/keywords/oncology |
| keywords[9].score | 0.4861607253551483 |
| keywords[9].display_name | Oncology |
| keywords[10].id | https://openalex.org/keywords/ipilimumab |
| keywords[10].score | 0.48469972610473633 |
| keywords[10].display_name | Ipilimumab |
| keywords[11].id | https://openalex.org/keywords/nivolumab |
| keywords[11].score | 0.4557572901248932 |
| keywords[11].display_name | Nivolumab |
| keywords[12].id | https://openalex.org/keywords/chimeric-antigen-receptor |
| keywords[12].score | 0.4403367042541504 |
| keywords[12].display_name | Chimeric antigen receptor |
| keywords[13].id | https://openalex.org/keywords/hematology |
| keywords[13].score | 0.4362955093383789 |
| keywords[13].display_name | Hematology |
| keywords[14].id | https://openalex.org/keywords/immune-system |
| keywords[14].score | 0.43156078457832336 |
| keywords[14].display_name | Immune system |
| keywords[15].id | https://openalex.org/keywords/internal-medicine |
| keywords[15].score | 0.3803994655609131 |
| keywords[15].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1186/s13045-024-01549-2 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S46507181 |
| locations[0].source.issn | 1756-8722 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1756-8722 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Hematology & Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | BioMed Central, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Hematology & Oncology |
| locations[0].landing_page_url | https://doi.org/10.1186/s13045-024-01549-2 |
| locations[1].id | pmid:38679698 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of hematology & oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38679698 |
| locations[2].id | pmh:oai:doaj.org/article:71b3951101c047dbb0dc7a737cd5954a |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-23 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/71b3951101c047dbb0dc7a737cd5954a |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11057182 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | J Hematol Oncol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11057182 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5104133376 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ke-Yu Shen |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I24943067, https://openalex.org/I4210159575 |
| authorships[0].affiliations[0].raw_affiliation_string | Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China |
| authorships[0].institutions[0].id | https://openalex.org/I24943067 |
| authorships[0].institutions[0].ror | https://ror.org/013q1eq08 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I24943067 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Fudan University |
| authorships[0].institutions[1].id | https://openalex.org/I4210159575 |
| authorships[0].institutions[1].ror | https://ror.org/05201qm87 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210159575 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Huashan Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ke-Yu Shen |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China |
| authorships[1].author.id | https://openalex.org/A5052189702 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5247-6324 |
| authorships[1].author.display_name | Ying Zhu |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I24943067, https://openalex.org/I4210159575 |
| authorships[1].affiliations[0].raw_affiliation_string | Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China |
| authorships[1].institutions[0].id | https://openalex.org/I24943067 |
| authorships[1].institutions[0].ror | https://ror.org/013q1eq08 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I24943067 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Fudan University |
| authorships[1].institutions[1].id | https://openalex.org/I4210159575 |
| authorships[1].institutions[1].ror | https://ror.org/05201qm87 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210159575 |
| authorships[1].institutions[1].country_code | CN |
| authorships[1].institutions[1].display_name | Huashan Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ying Zhu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China |
| authorships[2].author.id | https://openalex.org/A5049409719 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Sun‐Zhe Xie |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I24943067, https://openalex.org/I4210159575 |
| authorships[2].affiliations[0].raw_affiliation_string | Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China |
| authorships[2].institutions[0].id | https://openalex.org/I24943067 |
| authorships[2].institutions[0].ror | https://ror.org/013q1eq08 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I24943067 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Fudan University |
| authorships[2].institutions[1].id | https://openalex.org/I4210159575 |
| authorships[2].institutions[1].ror | https://ror.org/05201qm87 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210159575 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | Huashan Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sun-Zhe Xie |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 12 Urumqi Road (M), Shanghai, 200040, China |
| authorships[3].author.id | https://openalex.org/A5063254439 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4805-8239 |
| authorships[3].author.display_name | Lun–Xiu Qin |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I24943067 |
| authorships[3].affiliations[0].raw_affiliation_string | Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China |
| authorships[3].institutions[0].id | https://openalex.org/I24943067 |
| authorships[3].institutions[0].ror | https://ror.org/013q1eq08 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I24943067 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Fudan University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Lun-Xiu Qin |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W4380149783, https://openalex.org/W2188594974, https://openalex.org/W3167754811, https://openalex.org/W3005499534, https://openalex.org/W4385951209, https://openalex.org/W4386501485, https://openalex.org/W3041684384, https://openalex.org/W4402063613, https://openalex.org/W2898717093, https://openalex.org/W4379645133 |
| cited_by_count | 102 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 85 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 17 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s13045-024-01549-2 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S46507181 |
| best_oa_location.source.issn | 1756-8722 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1756-8722 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Hematology & Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | BioMed Central, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Hematology & Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s13045-024-01549-2 |
| primary_location.id | doi:10.1186/s13045-024-01549-2 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S46507181 |
| primary_location.source.issn | 1756-8722 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1756-8722 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Hematology & Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | BioMed Central, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-024-01549-2 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Hematology & Oncology |
| primary_location.landing_page_url | https://doi.org/10.1186/s13045-024-01549-2 |
| publication_date | 2024-04-29 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3128646645, https://openalex.org/W4232620598, https://openalex.org/W2595685820, https://openalex.org/W3152534107, https://openalex.org/W2624831627, https://openalex.org/W2982638381, https://openalex.org/W3212903603, https://openalex.org/W4294921564, https://openalex.org/W3119086885, https://openalex.org/W3169908766, https://openalex.org/W4377206081, https://openalex.org/W4291993576, https://openalex.org/W2098236252, https://openalex.org/W2615301036, https://openalex.org/W4212869333, https://openalex.org/W2966214074, https://openalex.org/W3104125801, https://openalex.org/W2007122139, https://openalex.org/W3213184315, https://openalex.org/W2923934428, https://openalex.org/W4294191660, https://openalex.org/W2930578043, https://openalex.org/W2900061537, https://openalex.org/W4206025283, https://openalex.org/W2938117370, https://openalex.org/W3085958090, https://openalex.org/W1675847437, https://openalex.org/W3034318868, https://openalex.org/W3120670329, https://openalex.org/W2796883066, https://openalex.org/W2999303877, https://openalex.org/W4308620781, https://openalex.org/W4281748563, https://openalex.org/W4386511183, https://openalex.org/W4361269840, https://openalex.org/W4388072313, https://openalex.org/W4360599629, https://openalex.org/W2950141726, https://openalex.org/W3199435130, https://openalex.org/W1871017309, https://openalex.org/W4213155622, https://openalex.org/W2909154636, https://openalex.org/W3013413712, https://openalex.org/W4380786205, https://openalex.org/W4224125304, https://openalex.org/W2885083500, https://openalex.org/W4291318725, https://openalex.org/W3127790723, https://openalex.org/W2617615447, https://openalex.org/W3110236571, https://openalex.org/W4291165538, https://openalex.org/W3087952073, https://openalex.org/W2559827832, https://openalex.org/W2899573186, https://openalex.org/W2466776366, https://openalex.org/W4285008554, https://openalex.org/W3015471245, https://openalex.org/W3197759322, https://openalex.org/W2954674882, https://openalex.org/W4283216044, https://openalex.org/W4214897653, https://openalex.org/W3189406047, https://openalex.org/W2918877774, https://openalex.org/W4221039330, https://openalex.org/W1993211204, https://openalex.org/W2122656254, https://openalex.org/W2952815301, https://openalex.org/W2912648593, https://openalex.org/W4385555589, https://openalex.org/W2046700010, https://openalex.org/W2810928105, https://openalex.org/W3180432427, https://openalex.org/W4381149624, https://openalex.org/W2884754721, https://openalex.org/W3017447724, https://openalex.org/W2149003918, https://openalex.org/W2108517168, https://openalex.org/W4391781585, https://openalex.org/W4392936715, https://openalex.org/W3201295484, https://openalex.org/W3118017075, https://openalex.org/W4283325186, https://openalex.org/W4226068368, https://openalex.org/W2204209053, https://openalex.org/W2795334950, https://openalex.org/W4386608057, https://openalex.org/W4221125550, https://openalex.org/W2185780593, https://openalex.org/W2889801069, https://openalex.org/W3015731029, https://openalex.org/W3159265081, https://openalex.org/W4377294019, https://openalex.org/W2767554904, https://openalex.org/W2144332166, https://openalex.org/W4214947450, https://openalex.org/W4385636695, https://openalex.org/W4323307028, https://openalex.org/W3133981801, https://openalex.org/W4318197608, https://openalex.org/W4392058000, https://openalex.org/W4381614877, https://openalex.org/W4390501952, https://openalex.org/W4323321646, https://openalex.org/W2962915255, https://openalex.org/W2934212324, https://openalex.org/W2112244490, https://openalex.org/W3011609327, https://openalex.org/W4294011912, https://openalex.org/W3120737456, https://openalex.org/W2626033245, https://openalex.org/W2949586081, https://openalex.org/W4290072634, https://openalex.org/W2052730188, https://openalex.org/W2606367731, https://openalex.org/W2805592007, https://openalex.org/W4200118825, https://openalex.org/W2990602950, https://openalex.org/W4310595719, https://openalex.org/W3025022288, https://openalex.org/W4200388794, https://openalex.org/W2890945215, https://openalex.org/W4291516836, https://openalex.org/W3121807241, https://openalex.org/W3166753505, https://openalex.org/W2775356055, https://openalex.org/W2791328450, https://openalex.org/W2158303916, https://openalex.org/W4387803249, https://openalex.org/W4308891835, https://openalex.org/W4385514156, https://openalex.org/W3045387409, https://openalex.org/W4389074118, https://openalex.org/W3216779670, https://openalex.org/W3093964219, https://openalex.org/W4385211938, https://openalex.org/W3090413519, https://openalex.org/W4386466411, https://openalex.org/W4386501485, https://openalex.org/W4319788181, https://openalex.org/W4323057661, https://openalex.org/W2916499417, https://openalex.org/W2955982848, https://openalex.org/W3088522482, https://openalex.org/W4391027452, https://openalex.org/W4224325284, https://openalex.org/W4205460569, https://openalex.org/W4211183255, https://openalex.org/W3211846837, https://openalex.org/W2048700210, https://openalex.org/W4205285388, https://openalex.org/W4379335103, https://openalex.org/W4286293838, https://openalex.org/W2909312563, https://openalex.org/W2908902954, https://openalex.org/W2794419219, https://openalex.org/W4224296508, https://openalex.org/W4223575919, https://openalex.org/W2295526061, https://openalex.org/W3165017392, https://openalex.org/W3110414417, https://openalex.org/W4365446441, https://openalex.org/W3010217167, https://openalex.org/W3119710582, https://openalex.org/W2126908586, https://openalex.org/W3023954831, https://openalex.org/W3142222967, https://openalex.org/W2887707004, https://openalex.org/W2999031113, https://openalex.org/W3183435229, https://openalex.org/W4386277279, https://openalex.org/W3088185527, https://openalex.org/W2562740476, https://openalex.org/W2510078407, https://openalex.org/W2972141850, https://openalex.org/W3125613997, https://openalex.org/W4320896665, https://openalex.org/W2793199674, https://openalex.org/W2914462041, https://openalex.org/W4366083443, https://openalex.org/W3215261291, https://openalex.org/W4366442582, https://openalex.org/W3124720941, https://openalex.org/W4296071823, https://openalex.org/W4210348552, https://openalex.org/W2606495925, https://openalex.org/W2018851752, https://openalex.org/W3108814053, https://openalex.org/W2945606195, https://openalex.org/W4200479826, https://openalex.org/W4366751298, https://openalex.org/W4385666602, https://openalex.org/W4385060096, https://openalex.org/W4225003254, https://openalex.org/W3125240514, https://openalex.org/W2770647635, https://openalex.org/W4310600375, https://openalex.org/W4309438509, https://openalex.org/W4315646654, https://openalex.org/W3031596442, https://openalex.org/W4313334574, https://openalex.org/W2097849707, https://openalex.org/W2093059993, https://openalex.org/W2948320538, https://openalex.org/W2016080258, https://openalex.org/W2119990616, https://openalex.org/W4220738859, https://openalex.org/W2788210656, https://openalex.org/W4294219364, https://openalex.org/W4281397351, https://openalex.org/W3171842402, https://openalex.org/W3017323680, https://openalex.org/W2606481717, https://openalex.org/W2098934164, https://openalex.org/W3109033328, https://openalex.org/W4232753183, https://openalex.org/W3157188545, https://openalex.org/W3047675473, https://openalex.org/W3174307488, https://openalex.org/W4303470795, https://openalex.org/W3121059150, https://openalex.org/W4226113050, https://openalex.org/W4220797604, https://openalex.org/W4226199204, https://openalex.org/W4207053320, https://openalex.org/W4200238068, https://openalex.org/W4256658815, https://openalex.org/W4361269839, https://openalex.org/W4226264221, https://openalex.org/W3203289704, https://openalex.org/W4200158019 |
| referenced_works_count | 230 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.49000000953674316 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99891292 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |